| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,386 |
6,793 |
$610K |
| 96401 |
|
760 |
669 |
$309K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
252 |
224 |
$92K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
141 |
131 |
$16K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
375 |
353 |
$15K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
423 |
392 |
$15K |
| 99215 |
Prolong outpt/office vis |
31 |
28 |
$5K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
13 |
13 |
$2K |
| 76881 |
|
25 |
25 |
$2K |
| J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
365 |
324 |
$0.00 |